...
首页> 外文期刊>American journal of clinical pathology. >Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification
【24h】

Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification

机译:乳腺核心穿刺活检对小叶肿瘤的后续手术切除的病理学发现以钙化

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to ascertain pathologic findings of surgical follow-up excision (FUE) on patients who had radiologic finding of calcifications and lobular neoplasia (LN) on core biopsy. Breast core biopsy specimens from 2006-2011 with a diagnosis of pure classic-type LN (lobular carcinoma in situ [LCIS] and atypical lobular hyperplasia [ALH]) with no history of invasive carcinoma (IC) or ductal carcinoma in situ (DCIS) were studied. Two hundred thirty-seven patients with the diagnosis of calcium on radiologic studies had FUE and were included in the study. Cases were divided into group 1 (pure ALH, n = 163) and group 2 (pure LCIS, n = 74). The interval between the core biopsy and FUE ranged from 0.2 to 7 months (mean, 1.5 ± 1.1 months). The risk of upstaging on FUE (DCIS or IC) is as follows: LCIS, 8.1% (6/74) and ALH, 3.1% (5/163). The data indicate that there is a low risk of upstaging to DCIS/IC from a core biopsy diagnosis of lobular neoplasia.
机译:这项研究的目的是确定在核心活检中有钙化和小叶增生(LN)影像学表现的患者的手术随访切除术(FUE)的病理学发现。 2006年至2011年诊断为单纯经典型LN(原位小叶癌[LCIS]和非典型小叶增生[ALH])的乳腺癌核心活检标本,无浸润癌(IC)或导管原位癌(DCIS)病史被研究了。在放射学研究中诊断为钙的237例患者发生FUE,并纳入研究。将病例分为1组(纯ALH,n = 163)和2组(纯LCIS,n = 74)。核心活检与FUE的间隔时间为0.2到7个月(平均1.5±1.1个月)。 FUE(DCIS或IC)升级的风险如下:LCIS为8.1%(6/74),ALH为3.1%(5/163)。数据表明,从小叶赘生物的核心活检诊断来看,升级为DCIS / IC的风险较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号